{"organizations": [], "uuid": "6f8d07a6e9d46b9775e623be1e39fdf59b1bda2b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-takedas-zika-vaccine-candidate-rec/brief-takedas-zika-vaccine-candidate-receives-u-s-fda-fast-track-status-idUSASB0C2PX", "country": "US", "domain_rank": 408, "title": "BRIEF-Takeda's Zika Vaccine Candidate Receives U.S. FDA Fast Track Status", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-29T15:15:00.000+02:00", "replies_count": 0, "uuid": "6f8d07a6e9d46b9775e623be1e39fdf59b1bda2b"}, "author": "", "url": "https://www.reuters.com/article/brief-takedas-zika-vaccine-candidate-rec/brief-takedas-zika-vaccine-candidate-receives-u-s-fda-fast-track-status-idUSASB0C2PX", "ord_in_thread": 0, "title": "BRIEF-Takeda's Zika Vaccine Candidate Receives U.S. FDA Fast Track Status", "locations": [], "entities": {"persons": [{"name": "reu", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "zika vaccine candidate receives u.s. fda", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "takeda pharmaceutical co ltd", "sentiment": "none"}, {"name": "takeda", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "takeda pharmaceutical co ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 16 PM / in 12 minutes BRIEF-Takeda's Zika Vaccine Candidate Receives U.S. FDA Fast Track Status Reuters Staff \nJan 29 (Reuters) - Takeda Pharmaceutical Co Ltd: \n* TAKEDA’S ZIKA VACCINE CANDIDATE RECEIVES U.S. FDA FAST TRACK DESIGNATION \n* TAKEDA PHARMACEUTICAL CO LTD SAYS FDA GRANTED FAST TRACK DESIGNATION TO TAK-426, CO‘S WHOLE ZIKA VIRUS VACCINE CANDIDATE  ", "external_links": [], "published": "2018-01-29T15:15:00.000+02:00", "crawled": "2018-01-29T15:33:06.006+02:00", "highlightTitle": ""}